hear3445

Nick Fitzgerald has served as HHTM’s Chief Marketing Officer for the past 3 years. He is the President and Owner of AuDSEO, a full service digital marketing agency. With over 15 years of digital marketing experience, Nick is a highly data-driven marketer, with expertise in search engine optimization, digital analytics and forensics, social media, digital advertising, and web development. He has been involved in the construction and optimization of nearly 1,000 web presences, including some of the largest Fortune 500 companies.
Featured image for “Oticon OTC Hearing Aids? William Demant Says it May Make OTC Devices if US Demand Develops”
Aug. 14, 2017

Oticon OTC Hearing Aids? William Demant Says it May Make OTC Devices if US Demand Develops

hear3445
William Demant Holdings, one of the world’s largest hearing aid manufacturers, said it could start producing less expensive Over-The-Counter (OTC) hearing aids for the U.S. market if demand increases after the OTC legislation goes into effect. North America represents the largest and most lucrative market for Demant, the parent company to well-known hearing aid brand Oticon. Shares of Demant, GN
Featured image for “UPDATE: US Diplomats in Cuba Mysteriously Suffer Severe Hearing Loss; Investigators Suspect Covert Sonic Weapon Used”
Aug. 10, 2017

UPDATE: US Diplomats in Cuba Mysteriously Suffer Severe Hearing Loss; Investigators Suspect Covert Sonic Weapon Used

hear3445
HAVANA, CUBA — The U.S. State Department recently expelled two Cuban diplomats in May, after several Americans at the US Embassy in Havana began suffering from unexplained medical symptoms late last year. According to a report from The Washington Post, a small number of Americans began reporting symptoms in the fall of 2016 and some of them were either removed
Featured image for “Former Intel Executive Appointed as New Starkey CTO and EVP of Engineering”
Aug. 08, 2017

Former Intel Executive Appointed as New Starkey CTO and EVP of Engineering

hear3445
EDEN PRAIRIE, MINNESOTA — Starkey Hearing Technologies announced the appointment this week of Achin Bhowmik, PhD, as its new Chief Technology Officer (CTO) and Executive Vice President of Engineering. In this new role, Dr. Bhowmik will be responsible for leading Starkey’s research and engineering efforts. Dr. Bhowmik is a well known authority in technology, with years of advanced research and product
Featured image for “Legislators Applaud Passage of OTC Hearing Aid Bill”
Aug. 07, 2017

Legislators Applaud Passage of OTC Hearing Aid Bill

hear3445
WASHINGTON, DC — Senators Elizabeth Warren (D-MA), Chuck Grassley (R-IA), Maggie Hassan (D-NH), Johnny Isakson (R-Ga.), Susan Collins (R-ME) and Claire McCaskill (D-MO), along with Representatives Joe Kennedy III (D-MA) and Marsha Blackburn (R-TN) applauded the passage of the Over-the-Counter (OTC) Hearing Aid Act as part of the Food and Drug Administration (FDA) Reauthorization Act last week. The bill passed
Featured image for “US Senate Passes OTC Hearing Aid Legislation”
Aug. 03, 2017

US Senate Passes OTC Hearing Aid Legislation

hear3445
WASHINGTON, DC — The US Senate passed the FDA Reauthorization Act today. The legislation, as reported previously, contains a provision that directs the FDA to develop a category of over-the-counter (OTC) hearing aids for adults with mild to moderate hearing loss. A House version of the bill was passed last month. The OTC provision of the legislation would allow for
Featured image for “NC Governor Signs Bill Allowing Deaf & HoH to Designate Hearing Status On Driver’s License”
Aug. 02, 2017

NC Governor Signs Bill Allowing Deaf & HoH to Designate Hearing Status On Driver’s License

hear3445
RALEIGH, NORTH CAROLINA — Late last week, North Carolina governor Roy Cooper signed a bill into law that allows people that are deaf and hard of hearing to have a symbol placed on their driver’s license that designates their hearing challenges. The bill, which unanimously passed both the state House and Senate, would allow for a special voluntary numeric and
Featured image for “Amplifon: Ready to Make “Major Acquisitions” to Maintain Position as World’s Top Hearing Aid Retailer”
Jul. 31, 2017

Amplifon: Ready to Make “Major Acquisitions” to Maintain Position as World’s Top Hearing Aid Retailer

hear3445
MILAN, ITALY — The world’s largest hearing aid retailer Amplifon SpA doesn’t plan to step aside while hearing aid manufacturers continue to acquire retailers across the globe. In a July 28 interview by Reuters, the company’s CEO says that Amplifon is ready to make “major acquisitions” in order to bolster the company’s position as the number 1 global retailer of
Featured image for “UPDATE: OTC Hearing Aid Legislation: Where Are We Now?”
Jul. 29, 2017

UPDATE: OTC Hearing Aid Legislation: Where Are We Now?

hear3445
Editor’s Note: On August 3, 2017, the US Senate passed the Over the Counter Act of 2017. The legislation, having already passed in the House, will now head to the president’s desk to be signed into law.   In November 2016, citing recommendations from the groundbreaking PCAST and NAS reports on hearing aid accessibility and affordability, US Senators Elizabeth Warren and
Featured image for “Auris Medical Acquires Meniere’s Drug, AM-125, from Otifex Therapeutics for Further Development”
Jul. 25, 2017

Auris Medical Acquires Meniere’s Drug, AM-125, from Otifex Therapeutics for Further Development

hear3445
ZUG, SWITZERLAND — Biopharmaceutical company Auris Medical Holdings announced today that it has completed the acquisition of assets related to intranasal betahistine from Otifex Therapeutics Ltd. The assets acquired by Auris Medical, including preclinical and clinical data, as well as intellectual property rights, have been fully transferred to Auris Medical according to the announcement. Together the assets form the foundation for further development of
Featured image for “Sound Pharmaceuticals Completes Clinical Trial Enrollment on Meniere’s Drug; GV Invests in Decibel Therapeutics”
Jul. 18, 2017

Sound Pharmaceuticals Completes Clinical Trial Enrollment on Meniere’s Drug; GV Invests in Decibel Therapeutics

hear3445
SEATTLE, WASHINGTON — Sound Pharmaceuticals, a Seattle-based biotech firm, announced late last month that it had completed enrollment on its first Ménière’s disease clinical trial. The clinical trial will use SPI-1005, an investigational new drug developed by the company that mimics and induces Glutathione Peroxidase (GPx), which has been shown to reduce the swelling or edema of the inner ear